Following the successful integrations of PharmEng Technology and Project Delivery Partners (PDP) earlier this year, Efor continues its targeted growth strategy with the acquisition of Process Engineering Specialists (PES), a well-established player based in Singapore. This third strategic acquisition marks another key milestone in Efor’s ambition to build a global leader in life sciences consulting by strengthening its presence in the rapidly expanding Asian market.
A key milestone in Efor’s international expansion strategy
The integration of PES confirms Efor’s bold development trajectory. Three acquisitions in less than a year demonstrate a strong and deliberate effort to build a group that is both global in scope and locally anchored in its delivery.
With over 3,200 employees across 17 countries, Efor continues to expand its international footprint and respond to the complex challenges facing the pharmaceutical, biotechnology, and medical device industries across the entire product lifecycle.
Strategic reinforcement in Asia
By joining Efor, PES brings a solid foundation in Asia, with teams based in Singapore, China, India, and Malaysia. Asia is rapidly becoming a key global hub for life sciences, driven by large-scale investments in biopharmaceutical manufacturing and a strong momentum in innovation.
This acquisition significantly enhances Efor’s ability to deliver on critical projects in the region, while offering support tailored to local expectations — including regulatory frameworks, timelines, and industrial practices.
Operational expertise to better serve clients
PES is renowned for its technical expertise in commissioning & qualification, process automation, and engineering project management. These capabilities further strengthen Efor’s ability to deliver robust, high-performance solutions adapted to the most demanding environments.
This new integration naturally complements the skills already added through PharmEng and PDP, enabling Efor to offer a more complete, consistent, and integrated service portfolio across all regions.
Global ambition, local execution
“With this third acquisition, we are reaching a new milestone in our journey to become a global leader in life sciences consulting,” said Mathieu Roger, Founder and President of Efor. “The integration of PES strengthens our presence in Asia with experienced, on-the-ground teams who share our commitment to excellence and engagement.”
Beyond geographic expansion, this acquisition reflects a strategy of focused consolidation: growing Efor while preserving its DNA by building on local hubs of excellence capable of delivering large-scale international projects.
A sustainable and integrated growth model
This latest transaction reinforces Efor’s clear strategy: to combine selective external growth with a high standard of operational quality. Each acquisition enriches a business model built on deep expertise, local proximity, and strong execution capabilities.
Rather than closing a chapter, this third acquisition opens new horizons — for Efor’s clients, its teams, and its ecosystem — all within a shared and sustainable vision for the transformation of the life sciences sector.
Previously published on Efor